{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:09:13Z","timestamp":1790287753712,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>PRAME (PReferentially expressed Antigen in MElanoma), a cancer testis antigen expressed in low levels in gonadal, endometrial, and adrenal gland tissues, has been recently considered a valuable tool in the differential diagnosis between benign and malignant melanocytic lesions. The aim of the current study is to perform PRAME immunostaining on a large series of benign and malignant acral lesions to evaluate the reproducibility of data reported in the literature and to validate PRAME as an affordable tool in the differential diagnosis between benign and malignant acral melanocytic tumors. Immunohistochemical analysis for PRAME was performed in 127 benign and malignant acral and nail melanocytic lesions. To better correlate PRAME expression with the nature (benign vs. malignant) of the lesions, we categorized PRAME tumor cells percentage positivity and intensity in a cumulative score obtained by adding the quartile of positive tumor cells (0, 1+, 2+, 3+, 4+) to PRAME expression intensity in tumor cells (0, 1+, 2+, 3+). Adopting an arbitrary PRAME expression score of &lt; 5 versus \u22655 resulted in a correct identification of 82.5% of benign and 87.1% of malignant lesions. PRAME immunohistochemistry demonstrated good sensitivity and specificity in the diagnosis of acral melanocytic lesions, however, in line with the previous literature, we identified a subset of challenging cases such as acral Spitz nevi, in situ melanomas, and small, thin, invasive melanomas in which PRAME did not correlate with morphologic features. This suggests that PRAME can be a valid tool to be incorporated in a diagnostic clinicopathologic algorithm, subject to morphologic characteristics.<\/jats:p>","DOI":"10.1097\/pas.0000000000001878","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T20:01:49Z","timestamp":1647028909000},"page":"579-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["Comparative Analysis of PRAME Expression in 127 Acral and Nail Melanocytic Lesions"],"prefix":"10.1097","volume":"46","author":[{"given":"Giacomo","family":"Santandrea","sequence":"first","affiliation":[{"name":"Pathology Unit"},{"name":"Clinical and Experimental Medicine PhD Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valli","sequence":"additional","affiliation":[{"name":"Pathology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Zanetti","sequence":"additional","affiliation":[{"name":"Pathology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Ragazzi","sequence":"additional","affiliation":[{"name":"Pathology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pampena","sequence":"additional","affiliation":[{"name":"Skin Cancer Center, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Longo","sequence":"additional","affiliation":[{"name":"Skin Cancer Center, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia"},{"name":"Department of Dermatology, University of Modena and Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Lai","sequence":"additional","affiliation":[{"name":"Skin Cancer Center, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia"},{"name":"Department of Dermatology, University of Modena and Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Piana","sequence":"additional","affiliation":[{"name":"Pathology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Cesinaro","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, Modena University Hospital, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00000372-200012000-00012","article-title":"A diagnosis for maniacs","volume":"22","author":"LeBoit","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/PAS.0b013e31802e63a2","article-title":"A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ","volume":"31","author":"Khalifeh","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5021\/ad.2011.23.2.246","article-title":"Acral pigmented spitz nevus that clinically mimicked acral lentiginous malignant melanoma","volume":"23","author":"Jang","year":"2011","journal-title":"Ann Dermatol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jmoldx.2013.04.001","article-title":"A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation","volume":"15","author":"Wang","year":"2013","journal-title":"J Mol Diagn"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/bmm.12.65","article-title":"The cancer testis antigen PRAME as a biomarker for solid tumor cancer management","volume":"6","author":"Goodison","year":"2012","journal-title":"Biomark Med"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jtho.2016.08.120","article-title":"Safety and immunogenicity of the PRAME cancer immunotherapeutic in patients with resected non-small cell lung cancer: a phase I dose escalation study","volume":"11","author":"Pujol","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R12-20250608","first-page":"4090","article-title":"Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?","volume":"58","author":"Neumann","year":"1998","journal-title":"Cancer Res"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"45352","DOI":"10.18632\/oncotarget.9977","article-title":"PRAME expression and promoter hypomethylation in epithelial ovarian cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/modpathol.2013.244","article-title":"Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma","volume":"27","author":"Hemminger","year":"2014","journal-title":"Mod Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cjp2.16","article-title":"Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma","volume":"1","author":"Iura","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1200\/JCO.2016.34.15_suppl.11067","article-title":"Expression and clinical correlations of PRAME in sarcoma subtypes","volume":"34","author":"Roszik","year":"2016","journal-title":"J Clin Oncol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.humpath.2016.12.006","article-title":"Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1","volume":"61","author":"Iura","year":"2017","journal-title":"Hum Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/PAS.0000000000001492","article-title":"Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/cup.13818","article-title":"PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cup.13876","article-title":"PRAME expression in 155 cases of metastatic melanoma","volume":"48","author":"Gradecki","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/his.14312","article-title":"PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna","volume":"78","author":"Gradecki","year":"2021","journal-title":"Histopathology"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cup.13958","article-title":"The utility of PRAME staining in identifying malignant transformation of melanocytic nevi","volume":"48","author":"Lohman","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cup.14130","article-title":"Preferentially expressed antigen in melanoma xand p16 expression in acral melanocytic neoplasms","volume":"49","author":"McBride","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/cup.14000","article-title":"The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors","volume":"48","author":"Alomari","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/thy.2009.0074","article-title":"A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates","volume":"19","author":"Marchetti","year":"2009","journal-title":"Thyroid"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/modpathol.2013.163","article-title":"MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study","volume":"27","author":"Shon","year":"2014","journal-title":"Mod Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","article-title":"Pleural mesothelioma classification update","volume":"478","author":"Beasley","year":"2021","journal-title":"Virchows Arch"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0002-9440(10)64393-3","article-title":"Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas","volume":"161","author":"Bastian","year":"2002","journal-title":"Am J Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pathol.2015.12.007","article-title":"Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.029","article-title":"Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions","volume":"58","author":"Harms","year":"2016","journal-title":"Hum Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAI.0000000000000511","article-title":"A diagnostic algorithm combining immunohistochemistry and molecular cytogenetics to diagnose challenging melanocytic tumors","volume":"26","author":"Redon","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/PAI.0000000000000428","article-title":"The p16-Ki-67-HMB45 immunohistochemistry scoring system is highly concordant with the fluorescent in situ hybridization test to differentiate between melanocytic nevi and melanomas","volume":"26","author":"Uguen","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/DAD.0000000000001951","article-title":"Correlation of FISH and PRAME immunohistochemistry in ambiguous superficial cutaneous melanocytic proliferations","volume":"43","author":"Harvey","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/modpathol.3800281","article-title":"Spitz nevi and atypical Spitz nevi\/tumors: a histologic and immunohistochemical analysis","volume":"18","author":"Kapur","year":"2005","journal-title":"Mod Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/DSS.0000000000000600","article-title":"Comparison of MITF and Melan-A immunohistochemistry during Mohs surgery for lentigo maligna-type melanoma in situ and lentigo maligna melanoma","volume":"42","author":"Christensen","year":"2016","journal-title":"Dermatol Surg"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/pde.13025","article-title":"Spitz Nevi and other spitzoid neoplasms in children: overview of incidence data and diagnostic criteria","volume":"34","author":"Dika","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"152550","DOI":"10.1016\/j.prp.2019.152550","article-title":"Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors","volume":"215","author":"Garola","year":"2019","journal-title":"Pathol Res Pract"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cup.12634","article-title":"Scattered atypical melanocytes with hyperchromatic nuclei in the nail matrix: diagnostic clue for early subungual melanoma in situ","volume":"43","author":"Park","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"e0136031","DOI":"10.1371\/journal.pone.0136031","article-title":"Routine clinical-pathologic correlation of pigmented skin tumors can influence patient management","volume":"10","author":"Longo","year":"2015","journal-title":"PLoS One"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:04:12Z","timestamp":1749416652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001878","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}